LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)
Public ClinicalTrials.gov record NCT01188928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study Comparing Once Daily Treatment With Calcipotriol 50 mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) Topical Suspension With Betamethasone 0.5 mg/g (as Dipropionate) in the Topical Suspension Vehicle, Calcipotriol 50 mcg/g in the Topical Suspension Vehicle and the Topical Suspension Vehicle Alone in Subjects With Psoriasis Vulgaris on Non-scalp Regions of the Body (Trunk and/or Limbs)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the efficacy and safety of Calcipotriol 50 Mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) Topical Suspension with the active components when used individually as monotherapy in the topical suspension vehicle (betamethasone dipropionate in the topical suspension vehicle, calcipotriol in the topical suspension vehicle) and with the topical suspension vehicle alone in the treatment of psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs) in a large phase 3 study. This comparison will ensure a more informed assessment of the benefit/risk ratio of Calcipotriol 50 Mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) Topical Suspension while also establishing the optimal treatment duration in psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs).
Study identification
- NCT ID
- NCT01188928
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,152 participants
Conditions and interventions
Conditions
Interventions
- Calcipotriol plus betamethasone Drug
- Betamethasone-17,21-dipropionate Drug
- Calcipotriene Drug
- Topical suspension vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Mar 2011 (Actual)
- Completion
- Mar 2011 (Actual)
- Last update posted
- Mar 10, 2025
2010 – 2011
United States locations
- U.S. sites
- 59
- U.S. states
- 23
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Horizon Research Group, Inc | Mobile | Alabama | 36606 | — |
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Advanced Clinical Research Institute | Anaheim | California | 92801 | — |
| DBA Torrance Clinical Research | Lomita | California | 90717 | — |
| Dermatology Specialists, Inc. | Oceanside | California | 92056 | — |
| Skin Surgery Medical Group, Inc. | San Diego | California | 92117 | — |
| Walter Nahm, MD, Ph.D., Inc | San Diego | California | 92123 | — |
| Coastal Medical Research Group, Inc. | San Luis Obispo | California | 93401 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Dermatology Research Centers | Santa Monica | California | 90404 | — |
| Colorado Medical Research Center, Inc. | Denver | Colorado | 80120 | — |
| Horizons Clinical Research Center, LLC | Denver | Colorado | 80220 | — |
| Visions Clinical Research | Boynton Beach | Florida | 33472 | — |
| Dermatology Associates and Research | Coral Gables | Florida | 33134 | — |
| North Florida Dermatology Associates, PA | Jacksonville | Florida | 32204 | — |
| International Dermatology Research, Inc. | Miami | Florida | 33144 | — |
| Ameriderm Research | Ormond Beach | Florida | 32174 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| Atlanta Dermatology, Vein & Research Center | Alpharetta | Georgia | 30022 | — |
| Peachtree Dermatology Associates | Atlanta | Georgia | 30327 | — |
| Dermatologic Surgery Specialists, PC | Macon | Georgia | 31217 | — |
| Gwinnett Clinical Research Center, Inc | Snellville | Georgia | 30078 | — |
| Altman Dermatology Associates | Arlington Hts | Illinois | 60005 | — |
| Glazer Dermatology | Buffalo Grove | Illinois | 60089 | — |
| Deaconess Clinic, Inc. | Evansville | Indiana | 47713 | — |
| Hudson Dermatology | Evansville | Indiana | 47714 | — |
| Dawes Fretzin Clinical Research Group | Indianapolis | Indiana | 46256 | — |
| Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Dermatology Specialists | Louisville | Kentucky | 40202 | — |
| Owensboro Dermatology Associates | Owensboro | Kentucky | 42303 | — |
| Lawrence J. Green, MD, LLC | Rockville | Maryland | 20850 | — |
| David Fivenson, MD Dermatology, PLC | Ann Arbor | Michigan | 48103 | — |
| Great Lakes Research Group, Inc | Bay City | Michigan | 48706 | — |
| Michigan Center for Research Corp., | Clinton Township | Michigan | 48038 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Somerset Skin Centre | Troy | Michigan | 48084 | — |
| Grekin Skin Institute | Warren | Michigan | 48088 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Karl G. Heine, M. D. Dermatology | Henderson | Nevada | 89052 | — |
| Psoriasis Treatment Center of Central NJ | East Windsor | New Jersey | 08520 | — |
| Anderson & Collins Clinical Research, Inc. | Edison | New Jersey | 08817 | — |
| The Dermatology Group, PC | Verona | New Jersey | 07044 | — |
| Academic Dermatology Associates | Albuquerque | New Mexico | 87106 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Derm Research Center of New York | Stony Brook | New York | 11790 | — |
| Triangle Medical Research Associates, LLC | Cary | North Carolina | 27518 | — |
| Haber Dermatology and Cosmetic Surgery | South Euclid | Ohio | 44118 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| King-Maceyko Dermatology Associates | Johnstown | Pennsylvania | 15905 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| J&S Studies, Inc. | College Station | Texas | 77845 | — |
| Division of Dermatology, Baylor Research Institute | Dallas | Texas | 75246 | — |
| Centre for Clinical Studies | Houston | Texas | 77030 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| Dermatology Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
| Progressive Clinical Research, P.A. | San Antonio | Texas | 78229 | — |
| Dermatology Research Center, Inc. | Salt Lake City | Utah | 84117 | — |
| Premier Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01188928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01188928 live on ClinicalTrials.gov.